A 5-Year Postmarketing Safety Study Of Xalcom In Patients With Open Angle Glaucoma Or Ocular Hypertension

Mise à jour : Il y a 4 ans
Référence : NCT00150267

Femme et Homme

Extrait

To estimate the frequency of patients with ocular/periorbital adverse events. To identify any possible long-term adverse consequences of increased iris pigmentation and to follow serious adverse events throughout the study period.


Critère d'inclusion

  • Glaucoma, Open-Angle ,Ocular hypertension


Liens